Pressmeddelande

Conference call regarding interim report Q1

Invitation to attend Surgical Science's conference call regarding presentation of the interim report January-March 2026. The presentation will be held in English.

Time: Wednesday, May 20 at 11:00 a.m. CEST

If you wish to participate via webcast, please use the link below. It will be possible to ask written questions via the webcast.
https://surgical-science-sweden.events.inderes.com/q1-report-2026/register

If you wish to participate via teleconference, please register via the link below. After registration, you will receive phone numbers and a conference ID to access the conference. It will be possible to ask oral questions via the telephone conference.
https://events.inderes.com/surgical-science-sweden/q1-report-2026/dial-in

Participants from Surgical Science are:
Tom Englund, CEO
Anna Ahlberg, CFO

A press release with Surgical Science's interim report for January-March 2026 will be published on May 20, 2026 at 07:30 a.m. CEST.

Prior to the start of the conference call, presentation material will be available on the company's website, under Investors, Presentations.

Gothenburg, Sweden, May 8, 2026
Surgical Science Sweden AB (publ)

The press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/investor-relations/#press-releases

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

About Surgical Science Sweden AB (publ)

Surgical Science is a global leader in evidence-based medical simulation. The company’s virtual reality simulators and customized training solutions enable surgeons and healthcare professionals to practice and improve their skills outside the operating room - enhancing patient safety and clinical outcomes. Also, Surgical Science partners with medical technology and robotics companies to integrate tailor-made simulation technology into their devices, helping them accelerate innovation and gain a competitive edge.

Surgical Science has approximately 320 employees. The company is headquartered in Gothenburg, Sweden, and has operations in Tel Aviv, Israel; Stockholm, Sweden; Cleveland, US; and Cardiff, UK. Through sales offices in these markets and in Shenzhen, China, as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market, Stockholm, Sweden. Certified Adviser is DNB Carnegie Investment Bank AB.